Mersana Therapeutics, Inc. (MRSN)
28.65
-0.08
(-0.28%)
USD |
NASDAQ |
Dec 30, 16:00
28.68
+0.03
(+0.10%)
After-Hours: 20:00
Mersana Therapeutics Total Assets (Quarterly): 62.69M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cidara Therapeutics, Inc. | 518.65M |
| Day One Biopharmaceuticals, Inc. | 513.78M |
| Semler Scientific, Inc. | 596.68M |
| Cue Biopharma, Inc. | 31.64M |
| Scholar Rock Holding Corp. | 411.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 122.22M |
| Shareholders Equity (Quarterly) | -59.54M |
| Debt to Equity Ratio | -0.0385 |
| Current Ratio | 1.386 |
| Net Debt Paydown Yield | 15.52% |